N-[3,5-Bis(trifluoromethyl)phenyl]-N'-[(1R,2R)-2-(dimethylamino)-1,2-diphenylethyl]thiourea, 97%, 100mg

2-Boc-6-Hydroxy-1,2,3,4-tetrahydro-isoquinoline-1-carboxylic acid, 97.0%, 5g

2-(1-(tert-Butoxycarbonyl)azetidin-3-yl)-2-methylpropanoic acid, 98%, 10g

1H-Indazole-6-carbonitrile, 97.0%, 250mg

2,5-di([1,1'-Biphenyl]-4-yl)-1,3,4-oxadiazole, 98%, 1g

1,4-DIOXASPIRO[4.5]DECAN-8-AMINE, 95.0%, 500mg

Flacons à fond plat ROTILABO® avec joint en verre rodé, 2000 ml, 45/40, 1 pièce

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(4-((tert-butoxycarbonyl)amino)phenyl)propanoic acid, 98%, 25g

6-Methyl-1H-indazol-5-ol, 95.0%, 250mg

Trimethylsilyl-1,2,3,4,5 pentamethyl-1,3-cyclopentadiene, >95.0%(GC), 1g

Methyl (2-imino-1,3-thiazolidin-3-yl)acetate hydrobromide, 95.0%, 500mg

4-Amino-2-chloro-5-methylpyrimidine, 95.0%, 250mg

2-Bromo-N,N-dimethylpyridine-4-amine, 95.0%, 5g